Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children

American Journal of Clinical Nutrition

Volumn 103, Issue 2, 2016, Pages 629S-634S

  Nandivada, Prathima ^a   Fell, Gillian L ^a   Gura, Kathleen M ^b   Puder, Mark ^a  

^a Vascular Biology Program   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Fish oil; Intestinal failure; Lipid emulsions; Liver disease; Parenteral lipids; PNALD; Soybean oil

Indexed keywords

FISH OIL; LIPID EMULSION; MIXED LIPID EMULSION; UNCLASSIFIED DRUG; SOYBEAN OIL;

ARTICLE; CHILD; HUMAN; INFANT; LIVER DISEASE; LONG TERM CARE; LOW FAT DIET; MONOTHERAPY; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE; ADVERSE EFFECTS; EVIDENCE BASED MEDICINE; HEPATIC INSUFFICIENCY; INFANT NUTRITION; INTESTINAL DISEASES; MULTIMODALITY CANCER THERAPY; NEWBORN; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PREMATURE BIRTH; PRESCHOOL CHILD; TRENDS;

CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; FAT EMULSIONS, INTRAVENOUS; FISH OILS; HEPATIC INSUFFICIENCY; HUMANS; INFANT; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INTESTINAL DISEASES; PARENTERAL NUTRITION; PRECISION MEDICINE; PREMATURE BIRTH; SOYBEAN OIL;

EID: 84956885626     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.114.103986     Document Type: Article

References (51)

1. Kelly DA. Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006;130(2 Suppl 1):S70-7.
2. Squires RH, Duggan C, Teitelbaum DH, Wales PW, Balint J, Venick R, Rhee S, Sudan D, Mercer D, Martinez JA, et al. Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium. J Pediatr 2012;161:723-8, e2.
3. Bishay M, Pichler J, Horn V, Macdonald S, Ellmer M, Eaton S, Hill S, Pierro A. Intestinal failure-associated liver disease in surgical infants requiring long-term parenteral nutrition. J Pediatr Surg [Internet] [cited 2014 Oct 28] 2012;47(2). Available from: http://www.ncbi.nlm.nih. gov/pubmed/22325390.
4. Tillman EM. Review and clinical update on parenteral nutritionassociated liver disease. Nutr Clin Pract [Internet] [cited 2014 Oct 28] 2013; 28(1). Available from: http://www.ncbi.nlm.nih.gov/pubmed/23087263.
5. Peyret B, Collardeau S, Touzet S, Loras-Duclaux I, Yantren H, Michalski MC, Chaix J, Restier-Miron L, Bouvier R, Lachaux A, et al. Prevalence of liver complications in children receiving long-term parenteral nutrition. Eur J Clin Nutr [Internet] [cited 2014 Oct 18] 2011; 65(6). Available from: http://www.ncbi.nlm.nih.gov/pubmed/21427734.
6. Kelly DA. Preventing parenteral nutrition liver disease. Early Hum Dev [Internet] [cited 2014 Oct 2] 2010;86(11). Available from: http://www.ncbi.nlm.nih.gov/pubmed/20923719.
7. Kurvinen A, Nissinen MJ, Gylling H, Miettinen TA, Lampela H, Koivusalo AI, Rintala RJ, Pakarinen MP. Effects of long-term parenteral nutrition on serum lipids, plant sterols, cholesterol metabolism, and liver histology in pediatric intestinal failure. J Pediatr Gastroenterol Nutr [Internet] [cited 2013 Apr 1] 2011;53(4). Available from: http://www.ncbi.nlm.nih.gov/pubmed/21543999.
8. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M, Milla PJ. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology [Internet] [cited 2013 Aug 12] 1993; 105(6). Available from: http://www.ncbi.nlm.nih.gov/pubmed/8253356.
9. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition [Internet] [cited 2013 Apr 1] 1998;14(1). Available from: http://www.ncbi.nlm.nih.gov/pubmed/9437703.
10. Chen W-Y, Lin S-Y, Pan H-C, Liao S-L, Chuang Y-H, Yen Y-J, Lin SY, Chen CJ. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats. J Nutr Biochem [Internet] [cited 2013 Apr 1] 2012;23(3). Available from: http://www.ncbi.nlm.nih.gov/pubmed/21497498.
11. Yeh SL, Chang KY, Huang PC, Chen WJ. Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition. Nutrition 1997;13:32-6.
12. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr [Internet] [cited 2013 Mar 28] 2000;24(6). Available from: http://www.ncbi.nlm. nih.gov/pubmed/11071594.
13. Wales PW, Allen N, Worthington P, George D, Compher C, Teitelbaum DASPEN. Clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr [Internet] [cited 2014 Sep 5] 2014;38(5). Available from: http://www.ncbi.nlm.nih.gov/pubmed/24696095.
14. Cober MP, Killu G, Brattain A, Welch KB, Kunisaki SM, Teitelbaum DH. Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease. J Pediatr [Internet] [cited 2013 Mar 28] 2012;160(3). Available from: http://www.ncbi.nlm.nih.gov/pubmed/21982303.
15. Innis SM. Essential fatty acid transfer and fetal development. Placenta [Internet] [cited 2013 Mar 28] 2005; 26(Suppl A). Available from: http://www.ncbi.nlm.nih.gov/pubmed/15837071.
16. Carnielli VP, Wattimena DJ, LuijenDijk IH, Boerlage A, Degenhart HJ, Sauer PJ. The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids. Pediatr Res [Internet] [cited 2013 Mar 28] 1996; 40(1). Available from: http://www.ncbi.nlm.nih.gov/pubmed/8798265.
17. Singh M. Essential fatty acids, DHA and human brain. Indian J Pediatr [Internet] [cited 2013 Mar 28] 2005;72(3). Available from: http://www.ncbi.nlm.nih.gov/pubmed/15812120.
18. Xu Z, Harvey KA, Pavlina T, Dutot G, Hise M, Zaloga GP, Siddigui RA. Steroidal compounds in commercial parenteral lipid emulsions. Nutrients [Internet] [cited 2013 Jul 12] 2012;4(8). Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3448078&tool= pmcentrez&rendertype=abstrac.t.
19. El Kasmi KC, Anderson AL, Devereaux MW, Vue PM, Zhang W, Setchell KDR, Karpen SJ, Sokol RJ. Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease. Sci Transl Med 2013;5:206ra137-8.
20. Ng K, Stoll B, Chacko S, Saenz de Pipaon M, Lauridsen C, Gray M, Squires EJ, Marini J, Zamora IJ, Olutoye OO, et al. Vitamin E in new-generation lipid emulsions protects against parenteral nutritionassociated liver disease in parenteral nutrition-fed preterm pigs. JPEN J Parenter Enteral Nutr [Internet] [cited 2015 Sep 3] 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25596209.
21. Vanek VW, Seidner DL, Allen P, Bistrian B, Collier S, Gura K, Miles JM, Valentine CJ, Kochevar M; Novel Nutrient Task Force, Intravenous Fat Emulsions Work Group, et al. A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract 2012;27:150-92.
22. Vanek VW, Seidner DL, Allen P, Bistrian B, Collier S, Gura K, Miles JM, Valentine CJ, Novel Nutrient Task Force, American Society for Parenteral and Enteral Nutrition. Update to A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract 2014;29:841.
23. Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics [Internet] [cited 2013 Aug 26] 2006; 118(1). Available from: http://www.ncbi.nlm.nih.gov/pubmed/16818533.
24. Gura KM, Lee S, Valim C, Zhou J, Kim S, MoDi BP, Arsenault DA, Strijbosch RA, Lopes S, Duggan C, et al. Safety and efficacy of a fish-oilbased fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008;121:e678-86.
25. Puder M, Valim C, Meisel J, Le HD, de Meijer VE, Robinson EM, Zhou J, Duggan C, Gura KM. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009;250:395-402.
26. Premkumar MH, Carter BA, Hawthorne KM, King K, Abrams SA. High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy. J Pediatr [Internet] [cited 2013 Mar 14] 2012;162(4). Available from: http://www.ncbi.nlm.nih.gov/pubmed/23164314.
27. Spencer AU, Neaga A, West B, Safran J, Brown P, Btaiche I, Kuzma-O'Reilly B, Teitelbaum DM. Pediatric short bowel syndrome. Trans Meet Am Surg Assoc 2005;123:102-10.
28. Willis TC, Carter BA, Rogers SP, Hawthorne KM, Hicks PD, Abrams SA. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 2010;34:32-7.
29. Calkins KL, Dunn JCY, Shew SB, Reyen L, Farmer DG, Devaskar SU, Venick RS. Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil. JPEN J Parenter Enteral Nutr [Internet] [cited 2013 Aug 12] 2013;38(6). Available from: http://www.ncbi.nlm.nih.gov/pubmed/23894176.
30. Yu X, Chan PL, Lee KH, Lee SC, Ng PC. A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis. Neonatology 2014;105(4):290-6.
31. Premkumar MH, Carter BA, Hawthorne KM, King K, Abrams SA. Fish oil-based lipid emulsions in the treatment of parenteral nutrition-associated liver disease: an ongoing positive experience. Adv Nutr 2014;5:65-70.
32. Nandivada P, Chang MI, Potemkin AK, Carlson SJ, Cowan E, O'loughlin AA, Mitchell PD, Gura KM, Puder M. The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy. Ann Surg 2015;26:172-9.
33. Gura KM, Parsons SK, Bechard LJ, Henderson T, Dorsey M, Phipatanakul W, Duggan C, Puder M, Lenders C. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr [Internet] [cited 2013 Apr 1] 2005;24(5). Available from: http://dx.doi.org/10.1016/j.clnu.2005.05.020.
34. St-Jules DE, Watters C, Iwamoto LM. Use of fish oil-based lipid emulsions in infants with intestinal failure-associated liver disease: a case series. Infant Child Adolesc Nutr 2014;6:6-13.
35. Alwayn IP, Gura K, Nose V, Zausche B, Javid P, Garza J, Verbesey J, Voss S, Ollero M, Andersson C, et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res 2005;57:445-52.
36. Wada M, DeLong CJ, Hong YH, Rieke CJ, Song I, Sidhu RS, Yuan C, Warnock M, Schmaier AH, Yokoyama C, et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem 2007; 282:22254-66.
37. Larson MK, Shearer GC, Ashmore JH, Anderson-Daniels JM, Graslie EL, Tholen JT, Vogelaar JL, Korth AJ, Nareddy V, Sprehe M, et al. Omega-3 fatty acids modulate collagen signaling in human platelets. Prostaglandins Leukot Essent Fatty Acids 2011;84(3-4):93-8.
38. Larson MK, Tormoen GW, Weaver LJ, Luepke KJ, Patel I, Hjelmen CE, Ensz NM, McComas LS, McCarty OJ. Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation. Am J Physiol Cell Physiol 2013;304:C273-9.
39. Dicken BJ, Bruce A, Samuel TM, Wales PW, Nahirniak S, Turner JM. Bedside to bench: the risk of bleeDing with parenteral omega-3 lipid emulsion therapy. J Pediatr 2014;164(3):652-4.
40. Turner JM, Field CJ, Goruk S, Wizzard P, Dicken BJ, Bruce A, Wales PW. Platelet arachidonic acid deficiency may contribute to abnormal platelet function during parenteral fish oil monotherapy in a piglet model. JPEN J Parenter Enteral Nutr [Internet] [cited 2015 Sep 26] 2015 Epub ahead(of print). Available from: http://www.ncbi.nlm.nih. gov/pubmed/25623480.
41. Friesecke S, Lotze C, Köhler J, Heinrich A, Felix SB, Abel P. Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med 2008;34:1411-20.
42. Muhammed R, Bremner R, Protheroe S, Johnson T, Holden C, Murphy MS. Resolution of parenteral nutrition-associated jaundice on changing from a soybean oil emulsion to a complex mixed-lipid emulsion. J Pediatr Gastroenterol Nutr [Internet] [cited 2013 Aug 25] 2012;54(6). Available from: http://www.ncbi.nlm.nih.gov/pubmed/22157927.
43. Sanchez SE, Braun LP, Mercer LD, Sherrill M, Stevens J, Javid PJ. The effect of lipid restriction on the prevention of parenteral nutritionassociated cholestasis in surgical infants. J Pediatr Surg [Internet] [cited 2013 Mar 28] 2013; 48(3). Available from: http://www.ncbi. nlm.nih.gov/pubmed/23480915.
44. Rollins MD, Ward RM, Jackson WD, Mulroy CW, Spencer CP, Ying J, Greene T, Book LS. Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease: a pilot study. J Pediatr Surg [Internet] [cited 2013 Aug 23] 2013;48(6). Available from: http://www.ncbi.nlm.nih.gov/pubmed/23845629.
45. Levit OL, Calkins KL, Gibson LC, Kelley-Quon L, Robinson DT, Elashoff DA, Grogan TR, Li N, Bizzarro MJ, Ehrenkranz RA. Low-dose intravenous soybean oil emulsion for prevention of cholestasis in preterm neonates. JPEN J Parenter Enteral Nutr [Internet] [cited 2014 Oct 28] 2014. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24963025.
46. Nehra D, Fallon EM, Carlson SJ, Potemkin AK, Hevelone ND, Mitchell PD, Gura KM, Puder M. Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr [Internet] [cited 2013 Mar 14] 2012;37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22767698.
47. Pawlik D, Lauterbach R, Walczak M, Hurka1a J, Sherman MP. Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study. JPEN J Parenter Enteral Nutr [Internet] [cited 2014 Nov 7] 2013;38(6). Available from: http://www.ncbi.nlm.nih.gov/pubmed/23963690.
48. Pawlik D, Lauterbach R, Turyk E. Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants. Pediatrics [Internet] [cited 2013 Mar 5] 2011;127(2). Available from: http://www.ncbi.nlm.nih.gov/pubmed/21199856.
49. Savini S, D'Ascenzo R, Biagetti C, Serpentini G, Pompilio A, Bartoli A, Cogo PE, Carnielli VP. The effect of 5 intravenous lipid emulsions on plasma phytosterols in preterm infants receiving parenteral nutrition: a randomized clinical trial. Am J Clin Nutr [Internet] [cited 2013 Aug 12] 2013;98(2). Available from: http://www.ncbi.nlm.nih.gov/pubmed/23761482.
50. Finn KL, Chung M, Rothpletz-Puglia P, Byham-Gray L. Impact of proviDing a combination lipid emulsion compared with a standard soybean oil lipid emulsion in children receiving parenteral nutrition: a systematic review and meta-analysis. JPEN J Parenter Enteral Nutr [Internet] [cited 2014 Oct 28] 2014. Available from: http://www.ncbi. nlm.nih.gov/pubmed/25057053.
51. Nehra D, Fallon EM, Potemkin AK, Voss SD, Mitchell PD, Valim C, Belfort MB, Bellinger DC, Duggan C, Gura KM, et al. A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial. JPEN J Parenter Enteral Nutr [Internet] [cited 2014 Oct 28] 2013;38(6). Available from: http://www.ncbi.nlm.nih.gov/pubmed/23770843.